The uptake of KIRESS, in 4T1 tumor-bearing BALB/c mice, was more efficient in primary tumor as well as in the bone marrow and spleen compared to non–tumor-bearing mice, allowing an easy access for SOCS3 mimetic to disseminated tumor cells in these organs. The gene discussed is SOCS3; the disease is neoplasm.